The risk-to-benefit ratio simply does not support the practice
Gabery S, Salinas CG, Paulsen SJ et al
M., Spindel, E
What it is: A once-weekly GLP-1 medicine for chronic weight management when combined with diet and activity How it works: Activates GLP-1 receptors in the brain and gut to reduce hunger and increase fullness What to expect: Many patients see steady weight loss over several months as the dose reaches a maintenance level Common considerations: Nausea, mild stomach discomfort, constipation, or diarrhea can occur during dose increases and usually improve with time and meal adjustments What it is: A once-weekly medicine that targets both GIP and GLP-1 receptors How it works: Adds a second pathway that further supports appetite control and metabolic health What to expect: Clinical studies have shown larger average weight reductions at higher doses compared with GLP-1 alone
They are ideal for individuals who maintain a healthy diet, engage in regular exercise, and are nearing their target weight
GLP-1 Tirz Tirzepatide GLP-1 Tirz 5mg (Lyophilized Peptide) For Research Use Only GLP-1 Tirz is a research-grade GLP-1 receptor agonist analog studied for its potential impact on appetite regulation, glucose control, insulin sensitivity, and metabolic health
